Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial

CHENGDU, China, April 29, 2024 /PRNewswire/ — Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report…

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

GAITHERSBURG, Md., April 29, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq:…

POSCO HOLDINGS INC. Files its Annual Report on Form 20-F

SEOUL, South Korea, April 29, 2024 /PRNewswire/ — On April 29, 2024, POSCO…

SK TELECOM CO. LTD. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 29, 2024 /PRNewswire/ — On April 29, 2024,…

Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024

MELBOURNE, Australia, April 29, 2024 /PRNewswire/ — Prota Therapeutics’ CEO Professor Mimi…

Neusoft Launches OneCoreGo® Global In-Vehicle Intelligent Mobility Solutions 5.0

BEIJING, April 29, 2024 /PRNewswire/ — Recently, at Auto China 2024, Neusoft…

DouYu International Holdings Limited Filed Its Annual Report on Form 20-F

WUHAN, China, April 29, 2024 /PRNewswire/ — DouYu International Holdings Limited ("DouYu"…

Canadian Solar Wins Green Project Bond of the Year Award by Environmental Finance

GUELPH, ON, April 29, 2024 /PRNewswire/ — Canadian Solar Inc. (the "Company", or…